Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US

Christopher M Blanchette1, Christopher Craver, Kathy W Belk

  • 1University of North Carolina , Charlotte, NC , USA.

Insights

Autosomal dominant polycystic kidney disease (ADPKD) patients utilize fewer hospital resources than chronic kidney disease (CKD) patients but experience more kidney complications and surgeries. This highlights the significant burden of ADPKD.

Area of Science:

  • Nephrology
  • Genetics
  • Healthcare Management

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a leading genetic cause of end-stage renal disease (ESRD).
  • Limited data exists on the healthcare resource utilization and patient characteristics for ADPKD.
  • Understanding ADPKD inpatient utilization is crucial for developing strategies to slow disease progression and reduce healthcare costs.

Purpose of the Study:

  • To assess hospital-based inpatient utilization among patients with ADPKD in the United States.
  • To compare patient characteristics and healthcare resource utilization between ADPKD and chronic kidney disease (CKD) cohorts.
  • To identify factors contributing to the healthcare burden of ADPKD.

Main Methods:

  • A cross-sectional analysis of 1876 hospitalized patients using MedAssets Health System Data.
  • Comparison of demographic, clinical characteristics, complications, surgical interventions, and length of stay between ADPKD and CKD patients.
  • Inclusion of measures like Charlson Comorbidity Score and primary payer information.

Main Results:

  • ADPKD patients were younger (mean 57.9 vs. 69.5 years) and generally healthier (Charlson Comorbidity Score 2.0 vs. 3.3) than CKD patients.
  • ADPKD patients had a shorter average hospital stay (6.3 vs. 10.3 days) and were more likely to have commercial insurance.
  • ADPKD patients showed higher rates of kidney-related complications and surgical procedures, primarily for transplant and nephrectomy.

Conclusions:

  • Despite being generally healthier, ADPKD patients face more frequent kidney-specific complications.
  • A higher incidence of major kidney procedures in ADPKD contributes significantly to inpatient resource utilization.
  • Further research is needed to manage ADPKD complications and optimize healthcare resource allocation.
Abstract

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...